Search research articles
Contact Us
Filters
Showing results (11-20 of 120) with videos related to
Page
of 12
Sort By:
Tissue Barriers
|
July 25, 2022
Interplay between EGFR, E-cadherin, and PTP1B in epidermal homeostasis
Tessa Arnaud, Fernando Rodrigues-Lima, Mireille Viguier, et al.
Neoplasia (New York, N.Y.)
|
November 26, 2024
Structure and function of the lysine methyltransferase SETD2 in cancer: From histones to cytoskeleton
Christina Michail, Fernando Rodrigues Lima, Mireille Viguier, et al.
Molecular Pharmacology
|
January 13, 2005
The xenobiotic-metabolizing enzymes arylamine N-acetyltransferases in human lens epithelial cells: inactivation by cellular oxidants and UVB-induced oxidative stress
Julien Dairou, François Malecaze, Jean-Marie Dupret, et al.
Methods in Enzymology
|
January 10, 2006
Inactivation of human arylamine N-acetyltransferase 1 by hydrogen peroxide and peroxynitrite
Jean-Marie Dupret, Julien Dairou, Noureddine Atmane, et al.
The Biochemical Journal
|
June 20, 2002
Biochemical identification of a neutral sphingomyelinase 1 (NSM1)-like enzyme as the major NSM activity in the DT40 B-cell line: absence of a role in the apoptotic response to endoplasmic reticulum stress
Amanda C Fensome, Michelle Josephs, Matilda Katan, et al.
Biochemical and Biophysical Research Communications
|
July 25, 2003
Reversible inhibition of the human xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 by S-nitrosothiols
Julien Dairou, Noureddine Atmane, Jean-Marie Dupret, et al.
The Journal of Biological Chemistry
|
December 16, 2003
Peroxynitrite irreversibly inactivates the human xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 (NAT1) in human breast cancer cells: a cellular and mechanistic study
Julien Dairou, Noureddine Atmane, Fernando Rodrigues-Lima, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
January 8, 2013
Crystal structure of arylamine N-acetyltransferases: insights into the mechanisms of action and substrate selectivity
Xavier Kubiak, Julien Dairou, Jean-Marie Dupret, et al.
British Journal of Pharmacology
|
December 17, 2013
Arylamine N-acetyltransferases: a structural perspective. Comments regarding the BJP paper by Zhou et al., 2013
Ximing Xu, Xavier Kubiak, Jean-Marie Dupret, et al.
Current Drug Targets
|
January 1, 2010
Human arylamine N-acetyltransferase 1: a drug-metabolizing enzyme and a drug target?
Fernando Rodrigues-Lima, Julien Dairou, Florent Busi, et al.
Page
of 12
Search research articles
Search
Showing results (11-20 of 120) with videos related to
Sort By:
Page
of 12
Tissue Barriers
|
July 25, 2022
Interplay between EGFR, E-cadherin, and PTP1B in epidermal homeostasis
Tessa Arnaud, Fernando Rodrigues-Lima, Mireille Viguier, et al.
Neoplasia (New York, N.Y.)
|
November 26, 2024
Structure and function of the lysine methyltransferase SETD2 in cancer: From histones to cytoskeleton
Christina Michail, Fernando Rodrigues Lima, Mireille Viguier, et al.
Molecular Pharmacology
|
January 13, 2005
The xenobiotic-metabolizing enzymes arylamine N-acetyltransferases in human lens epithelial cells: inactivation by cellular oxidants and UVB-induced oxidative stress
Julien Dairou, François Malecaze, Jean-Marie Dupret, et al.
Methods in Enzymology
|
January 10, 2006
Inactivation of human arylamine N-acetyltransferase 1 by hydrogen peroxide and peroxynitrite
Jean-Marie Dupret, Julien Dairou, Noureddine Atmane, et al.
The Biochemical Journal
|
June 20, 2002
Biochemical identification of a neutral sphingomyelinase 1 (NSM1)-like enzyme as the major NSM activity in the DT40 B-cell line: absence of a role in the apoptotic response to endoplasmic reticulum stress
Amanda C Fensome, Michelle Josephs, Matilda Katan, et al.
Biochemical and Biophysical Research Communications
|
July 25, 2003
Reversible inhibition of the human xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 by S-nitrosothiols
Julien Dairou, Noureddine Atmane, Jean-Marie Dupret, et al.
The Journal of Biological Chemistry
|
December 16, 2003
Peroxynitrite irreversibly inactivates the human xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 (NAT1) in human breast cancer cells: a cellular and mechanistic study
Julien Dairou, Noureddine Atmane, Fernando Rodrigues-Lima, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
January 8, 2013
Crystal structure of arylamine N-acetyltransferases: insights into the mechanisms of action and substrate selectivity
Xavier Kubiak, Julien Dairou, Jean-Marie Dupret, et al.
British Journal of Pharmacology
|
December 17, 2013
Arylamine N-acetyltransferases: a structural perspective. Comments regarding the BJP paper by Zhou et al., 2013
Ximing Xu, Xavier Kubiak, Jean-Marie Dupret, et al.
Current Drug Targets
|
January 1, 2010
Human arylamine N-acetyltransferase 1: a drug-metabolizing enzyme and a drug target?
Fernando Rodrigues-Lima, Julien Dairou, Florent Busi, et al.
Page
of 12